Trial intelligence / Profile preview

DACLEAN: Sodium Hypochlorite for PVC Disinfection

NCT04391660Phase 4Completed

Sponsor
CHU de Poitiers
Start
Jun 2020
Primary completion
Jan 2021
Modality
Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of sodium hypochlorite in catheter colonization and catheter-related bloodstream infection (CRBSI) (2 arms), sponsored by CHU de Poitiers. Primary endpoint: Incidence of colonized catheters at 14 days. Started Jun 2020; status: completed.

02

Drugs

sodium hypochlorite
03

Conditions

catheter colonizationcatheter-related bloodstream infection (CRBSI)

Beyond the preview

Go deeper on NCT04391660.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04391660.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call